Viewing Study NCT00003335


Ignite Creation Date: 2025-12-24 @ 10:09 PM
Ignite Modification Date: 2026-02-22 @ 4:13 PM
Study NCT ID: NCT00003335
Status: COMPLETED
Last Update Posted: 2012-03-15
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
Sponsor: Case Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Graft Versus Host Disease View
None Leukemia View
None Lymphoma View
None Myelodysplastic Syndromes View
None Myelodysplastic/Myeloproliferative Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent childhood acute lymphoblastic leukemia View
None recurrent childhood lymphoblastic lymphoma View
None recurrent adult acute lymphoblastic leukemia View
None chronic phase chronic myelogenous leukemia View
None accelerated phase chronic myelogenous leukemia View
None blastic phase chronic myelogenous leukemia View
None untreated childhood acute lymphoblastic leukemia View
None adult acute myeloid leukemia in remission View
None adult acute lymphoblastic leukemia in remission View
None childhood acute myeloid leukemia in remission View
None childhood acute lymphoblastic leukemia in remission View
None adult acute erythroid leukemia (M6) View
None adult acute megakaryoblastic leukemia (M7) View
None childhood acute erythroleukemia (M6) View
None childhood acute megakaryocytic leukemia (M7) View
None refractory anemia with excess blasts View
None refractory anemia with excess blasts in transformation View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent adult Burkitt lymphoma View
None de novo myelodysplastic syndromes View
None previously treated myelodysplastic syndromes View
None secondary myelodysplastic syndromes View
None graft versus host disease View
None adult acute minimally differentiated myeloid leukemia (M0) View
None childhood acute minimally differentiated myeloid leukemia (M0) View
None recurrent childhood small noncleaved cell lymphoma View
None recurrent childhood large cell lymphoma View
None recurrent mantle cell lymphoma View
None childhood chronic myelogenous leukemia View
None atypical chronic myeloid leukemia View
None myelodysplastic/myeloproliferative disease, unclassifiable View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None nodal marginal zone B-cell lymphoma View
None splenic marginal zone lymphoma View
None adult acute myeloid leukemia with t(8;21)(q22;q22) View
None adult acute myeloid leukemia with t(16;16)(p13;q22) View
None adult acute myeloid leukemia with inv(16)(p13;q22) View
None adult acute myeloid leukemia with 11q23 (MLL) abnormalities View
None adult acute myeloid leukemia with t(15;17)(q22;q12) View
None childhood myelodysplastic syndromes View